Acceder

Publicaciones - Tromboembolismo venoso

Cargando...
Ruiz-Artacho P, Lecumberri R, Trujillo-Santos J, Font C, Lopez-Nunez JJ, Peris ML, Diaz Pedroche C, Lobo JL, Lopez Jimenez L, Lopez Reyes R, Jara Palomares L, Pedrajas JM, Mahe I, Monreal M, The Riete Investigators. Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism. Cancers (Basel). 2022 Aug 26;14(17):4127. doi: 10.3390/cancers14174127. PubMed PMID: 36077663; PubMed Central PMCID: PMC9454710.
AÑO: 2022; IF: 6.575
Bikdeli B, Caraballo C, Trujillo-Santos J, Galanaud JP, di Micco P, Rosa V, Cusido GV, Schellong S, Mellado M, Del Valle Morales M, Gavin-Sebastian O, Mazzolai L, Krumholz HM, Monreal M; RIETE Investigators. Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry. JAMA Cardiol. 2022 Aug 1;7(8):857-865. doi: 10.1001/jamacardio.2022.1988. PubMed PMID: 35830171; PubMed Central PMCID: PMC9280612.
AÑO: 2022; IF: 24.0
Mora D, Nieto JA, Mateo J, Bikdeli B, Barco S, Trujillo-Santos J, Soler S, Font L, Bosevski M, Monreal M; RIETE Investigators. Machine Learning to Predict Outcomes in Patients with Acute Pulmonary Embolism Who Prematurely Discontinued Anticoagulant Therapy. Thromb Haemost. 2022 Apr;122(4):570-577. doi: 10.1055/a-1525-7220. Epub 2022 Jul 13. PubMed PMID: 34107539.
AÑO: 2022; IF: 6.7
Trujillo-Santos J, Farge-Bancel D, Pedrajas JM, Gomez-Cuervo C, Ballaz A, Braester A, Mahe I, Villalobos A, Porras JA, Monreal M; RIETE Investigators. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study. Res Pract Thromb Haemost. 2022 Jun 3;6(4):e12736. doi: 10.1002/rth2.12736. eCollection 2022 May. PubMed PMID: 35664535; PubMed Central PMCID: PMC9164243.
AÑO: 2022; IF: 5.953
Lecumberri R, Ruiz-Artacho P, Tzoran I, Brenner B, Farge-Bancel D, Ay C, Rosa V, Francisco I, Hernandez-Blasco LM, Trujillo-Santos J, Monreal M; RIETE Investigators. Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid Tumors. Thromb Haemost. 2022 Sep;122(9):1594-1602. doi: 10.1055/a-1777-4006. Epub 2022 Feb 21. PubMed PMID: 35189661.
AÑO: 2022; IF: 6.7
Siguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII